Target intelligence / Profile preview

Transient Receptor Potential Vanilloid Type 1 (TRPV1)

Target
TRPV1
Molecular classification
Ion channel, Receptor
01

Overview

TRPV1 is a non-selective cation channel that acts as a detector of noxious heat, acidic conditions, capsaicin, and other stimuli. It plays a key role in pain sensation and is predominantly expressed in peripheral nociceptive sensory neurons. Altered TRPV1 function is linked to chronic pain states, making it a therapeutic target for analgesics. Activation leads to influx of cations, primarily Ca2+ and Na+, causing depolarization and pain signal propagation. It can be activated/sensitized by exogenous activators like capsaicin and endogenous modulators such as protons and endocannabinoids. Inflammatory mediators also sensitize the receptor, contributing to hyperalgesia and allodynia. The channel has a tetrameric structure with each subunit containing six transmembrane domains. Cryo-electron microscopy reveals its fourfold symmetry and cytoplasmic basket-like domains.

Other names
Capsaicin receptorVanilloid receptor 1
02

Mechanism of action

Influx of cations (Ca2+, Na+) leading to depolarization of sensory neurons and propagation of pain signals; Sensitization by pro-inflammatory mediators (prostaglandins, bradykinin, NGF, ATP)

03

Biological functions

Detection/regulation of body temperatureSensation of scalding heat/painModulation/integration of diverse painful stimuliNociception
04

Disease associations

InflammationChronic pain states
05

Safety considerations

Side effects associated with TRPV1 antagonistsTherapeutic challenges in developing safer modulators
06

Interacting drugs

Capsaicin

5 more in the full profile.

Beyond the preview

Go deeper on Transient Receptor Potential Vanilloid Type 1 (TRPV1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transient Receptor Potential Vanilloid Type 1 (TRPV1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call